STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await

Written and edited by the WorldPing NewsdeskPublished Thu, 01 Oct 2026 10:30:00 UTCUpdated Thu, 01 Oct 2026 10:30:00 UTCOriginal reporting: STAT

What happened

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Living hubs that keep updating as this story develops.

WorldPing

Gizmodo

The EU executive branch implemented a non-US-made backup to Teams. One staffer called it "absolute sh*t".

Brief by WorldPing · Original reporting by Gizmodo

WorldPing

The Hindu

The two F-16V Block 70 jets landed at Chihhang Air Base in Taitung.

Brief by WorldPing · Original reporting by The Hindu

WorldPing

Engadget

If you can live without deep iOS integration and the polished design of the AirPods Max, you could save hundreds.

Brief by WorldPing · Original reporting by Engadget